News: Medical Technology

View:
 

Found press releases

 

Bytec display arms offer fast installation and simple cable management

1/23/2012 7:09 AM EST  -   Bytec
Installation and maintenance carried out in-situ without specialist equipment
Redhill, UK, 23 January 2012 – Bytec Medical’s new mounting arms for display screens and equipment feature a patent pending design that allows cables to be easily fed through the arms to give a tidy and ultra-quick installation.

Bytec has based its new arm design on extensive ergonomic research at hospitals and other health...

Sectra to provide suite of integrated radiology IT solutions to Nashville Genera...

1/16/2012 3:00 AM EST  -   SECTRA
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry.  Sectra’s suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
JAOtech is launching its full range of Smart Terminals and Smart HDTVs at Arab Health, including the Inix Smart TV and accessories including ceiling/wall arms.
 

Bedside computing specialist launches in Middle East

1/13/2012 6:30 AM EST  -   JAOtech
Arab Health, Dubai, 23 – 26 January 2012

Stand Number 7D15
Redhill, 12 January 2012 – JAOtech, a world leader in patient bedside computing solutions, is launching its full range of Smart Terminals and Smart Healthcare TVs into the Middle Eastern market at Arab Health, and appointing an Area Sales Manager to strengthen its customer relationships in the region. The JAOtech booth at Arab Health (7D15) will...

Bluefish expands product portfolio further

12/30/2011 5:34 AM EST  -   Bluefish Pharmaceuticals AB
Bluefish has signed a new license agreement for another 15 products. The portfolio now consists of 83 products, whereof 44 have been launched. The new products belong to a variety of therapeutic categories, including cardiovascular disease, depression, viral disease, oncology, inflammation and gastrointestinal disease, with an aggregated market value in the EU of SEK 46 billion.

ContextVision press releases and reports 2011

12/28/2011 1:22 PM EST  -   ContextVision AB
Please find below an overview over ContextVision's press releases and reports 2011.

 

17.02.2011        ContextVision presents Q4 and full year 2010

03.03.2011        ContextVision launches first product from strategic alliance with Neusoft

03.03.2011        ContextVision launches new product for Real-Time Fluoroscopy Images

11.04.2011        ContextVision Unveils New Cutting Edge Ultrasound Image Enhancement...

ContextVision Financial Calender 2012

12/28/2011 1:01 PM EST  -   ContextVision AB
Please find below information on the reporting dates 2012 and the AGM.

Q4 and 12 months 2011 report                              February 23, 2012

Q1 2012 report                                                     April 26, 2012

Annual General Meeting                                         June 13, 2012

Q2 2012 report                                                     August 23, 2012

Q3 2012...

Bluefish completes directed new share issue – provides SEK 19.5 million

12/27/2011 3:30 AM EST  -   Bluefish Pharmaceuticals AB
The Board of Directors in Bluefish Pharmaceuticals AB (Bluefish) has decided to complete a directed new share issue to Whochford Holding (Whochford) equivalent to SEK 19.5 million. The decision is conditioned by the general meeting’s subsequent approval. After the new share issue, Whochford will hold 7.1% of the capital and votes in Bluefish.

”Whochford is an investment company in South Asia that is well...

Sectra’s six-month interim report for 2011/2012: Sectra's earnings boosted by ca...

12/6/2011 2:00 AM EST  -   SECTRA
IT and medical technology company Sectra reported a profit after tax of SEK 340.0 million for the six-month period, May – October 2011, including the operation being discontinued. The profit includes a preliminary capital gain of SEK 322.6 million generated by the divestment of the MicroDose operations, which was finalized during the second quarter.
Sectra’s net sales for the six-month period amounted to SEK...

Bluefish completes directed new share issue - provides SEK 40 million

12/6/2011 1:30 AM EST  -   Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB (Bluefish) has completed a directed new share issue to Nexttobe AB (nxt2b) equivalent to SEK 40 million. After the new share issue, nxt2b will hold 15.7% of the capital and votes in Bluefish.

nxt2b is a privately owned investment company that was founded in 2011 by the Swedish entrepreneur Bengt Ågerup.

”nxt2b has extensive experience from the pharmaceutical industry and we look forward...

Mission-Critical Innovation Awards to University Hospitals using Sectra’s IT sol...

11/29/2011 3:44 AM EST  -   SECTRA
University Hospitals in Cleveland (UH), USA, has been announced the winner in the category “Humanitarian/Environmental Impact” in the Mission-Critical Innovations Awards, a worldwide competition presented by HP and Intel®. The competition has rewarded UH for its disaster-tolerant Sectra PACS solution for processing and archiving of digital radiology images.
UH provides continuous healthcare for patients across...